Skip to main content

Day: April 26, 2024

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., April 26, 2024 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 5,400 shares of its common stock under the Company’s 2023 Inducement Plan. The stock options will vest over a four-year period, with 25% of each of the options vesting on the first anniversary of such employee’s start date, and 1/48th of the total shares vesting monthly thereafter, subject to continued employment on each vesting date. About Tempest TherapeuticsTempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of...

Continue reading

Dynagas LNG Partners LP Announces Filing of Form 20-F With the SEC

ATHENS, Greece, April 26, 2024 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (the “Partnership”) (NYSE: DLNG), an owner and operator of liquefied natural gas (“LNG”) carriers, announced today that it has filed its Annual Report on Form 20-F for the year ended December 31, 2023 (the “Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”). The Annual Report is available through the Partnership’s website. Alternatively, unitholders may also receive a hard copy of the Annual Report, including the Partnership’s audited annual financial statements, free of charge, by request to Capital Link, Inc., using the contact details provided at the end of this press release. About Dynagas LNG Partners LPDynagas LNG Partners LP. (NYSE: DLNG) is a master limited partnership which owns and operates liquefied natural gas (LNG) carriers...

Continue reading

Diamondback Energy, Inc. Receives Stockholder Approval for Proposed Transaction with Endeavor Energy Resources, L.P.

MIDLAND, Texas, April 26, 2024 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback” or the “Company”) today announced that its stockholders have approved the issuance of shares of Diamondback common stock in connection with the proposed business combination with Endeavor Energy Resources, L.P. (“Endeavor”). Additionally, Diamondback stockholders approved a proposal to amend the Company’s certificate of incorporation to increase the authorized number of shares of Diamondback common stock. The final voting results from Diamondback’s special meeting of stockholders will be set forth in a Form 8-K to be filed by Diamondback with the U.S. Securities and Exchange Commission. The business combination with Endeavor is subject to customary closing conditions, including termination or expiration of the waiting period...

Continue reading

DDC Enterprise Limited Reports on NYSE American Noncompliance Notice

NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) — DDC ENTERPRISE LIMITED (NYSE AMERICAN: DDC) (“DAYDAYCOOK” OR THE “COMPANY”) announced today that on April 23, 2024, the Company received notice from NYSE American (the “Exchange”) that the Company currently is below the Exchange’s continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide, which requires the Company to have stockholders’ equity of $2.0 million or more if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years. The Exchange indicated that because the Company reported stockholders’ deficit of $(222,572,936) on June 30, 2023 and losses from continuing operations and/or net losses in its two most recent fiscal years ended December 31, 2022, the Company was not in compliance with Section...

Continue reading

Blackwell 3D Announces a $500,000 Public Offering Under Regulation A+

DUBAI, UAE, April 26, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Blackwell 3D Construction Corp. (OTC: BDCC) (“Blackwell 3D” or the “Company”), The Company is pleased to announce the launch of a Regulation A+, Tier 1, equity financing of up to $500,000 dollars (the “Public Offering”). This Public Offering is a landmark event for the Company as it allows any individual 18 years or older to invest directly in the Company by purchasing freely tradable shares of our common stock. A copy of the Company’s offering circular for the Public Offering can be found on the Securities & Exchange Commission’s (“SEC”) website at https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&filenum=024-12412. Blackwell 3D is an innovative 3D house printing technology company focused on revolutionizing the construction industry by printing...

Continue reading

Fentura Financial, Inc. Announces First Quarter 2024 Earnings (Unaudited)

Dollars in thousands except per share amounts. Certain items in the prior period financial statements have been reclassified to conform with the March 31, 2024 presentation. FENTON, Mich., April 26, 2024 (GLOBE NEWSWIRE) — Fentura Financial, Inc. (OTCQX: FETM) announces quarterly net income results of $2,790 for the three months ended March 31, 2024. Ronald L. Justice, President and CEO, stated, “I am pleased with the progress we continue to make navigating a difficult operating environment as a result of challenges created by a multi-decades high increase in short-term interest rates over the last twenty-four months and a historically long and deep inversion of the yield curve. While this has impacted the level of profitability we experienced prior to this period, we ended the first quarter with record total assets and shareholders’...

Continue reading

Oxford Square Capital Corp. Schedules First Quarter 2024 Earnings Release and Conference Call for May 2, 2024

GREENWICH, Conn., April 26, 2024 (GLOBE NEWSWIRE) — Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) announced today that it will hold a conference call to discuss first quarter 2024 earnings on Thursday, May 2, 2024 at 9:00 AM Eastern time. The toll free dial-in number is 1-800-445-7795, verbal access code is OXFORD. There will be a recording available for 30 days after the call. If you are interested in hearing the recording, please dial 1-877-693-4280. The replay verbal passcode is OXFORD. About Oxford Square Capital Corp.Oxford Square Capital Corp. is a publicly-traded business development company principally investing in syndicated bank loans and debt and equity tranches of collateralized loan obligation (“CLO”) vehicles. CLO investments may also include warehouse facilities, which are financing...

Continue reading

Bigbank’s Unaudited Financial Results for Q1 2024

Bigbank’s total gross loan portfolio grew to a record 1.75 billion euros by the end of the first quarter, increasing by 86 million euros (+5%) over the quarter and by 325 million euros (+23%) year-on-year. During the quarter, the corporate loan portfolio grew by 22 million euros (+4%) to 600 million euros, the housing loan portfolio by 43 million euros (+12%) to 394 million euros and the consumer loan portfolio by 25 million euros (+3%) to 762 million euros. The savings deposit portfolio and the term deposit portfolio grew at fairly equal rates in the first quarter. The Group’s total deposit portfolio increased by 215 million euros (+11%) over the quarter and by 655 million euros (+44%) year-on-year, expanding to 2.15 billion euros. The term deposit portfolio increased by 100 million euros (+11%) to 1.02 billion euros, exceeding the 1-billion-euro...

Continue reading

Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio

BEIJING, China, April 26, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Sino Biological, Inc.(“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), specializing in biological research reagents and related technical contract research services, has successfully concluded its acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc. (“SCB” or “SignalChem”). Sino Biological has acquired 100% of SCB shares in a deal valued at $48M USD, inclusive of all assets, assumed indebtedness, and net of cash deposits.   SignalChem Biotech Inc. is renowned for its specialized bioactive enzymes, including kinases, proteases, phosphatases, ubiquitin and epigenetic enzymes. Over the past two decades, SCB has established...

Continue reading

SYNERGIE : SYNERGIE announces the release of its 2023 Annual Financial Report

SYNERGIE announces the release of its2023 Annual Financial Report Paris, 26 April 2024: SYNERGIE announces that its 2023 Annual Financial Report (french version) is available on its website www.synergie.com About SYNERGIE A European specialist in Human Resources Management, SYNERGIE covers all employment-related needs. With a network of 800 branches in Europe, Canada and Australia, the Group generated a 2023 consolidated revenue of €3,108.5 million, which international business accounted for 58%. The strategy employed by SYNERGIE Group is based on an active organic and external growth policy that is intended to strengthen its positioning as a key European actor. Euronext Paris Compartiment B ISIN FR0000032658, mnémo SDGReuters SDGI.PA, Bloomberg SDG:FPwww.synergie.com 160 bis rue de Paris – 92100 Boulogne BillancourtSE (European...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.